| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |